NCT06627634

Radical Surgery for Advanced Gastric- or GEJ-cancer With Oligometastatic Dissmination to the Liver

Gastric Cancer and Oligometastatic Liverinvolvement. Metastatectomy and Impact on Survival

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Aarhus University Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Offering treatment with potential to cure for participants with no such offer in today's standard treatment options, by offering metastatectomia and standard treatment with intention to cure i.e., neoadjuvant chemotherapy and gastrectomy for participants with gastric- og gastroeusofageal junction cancer. Including 20 participants from all 4 centres in Denmark able to perform the surgical procedures in question. Endpoints: 2-year overall survival.

Conditions

• Survival

Interventions

Type	Name	Description
PROCEDURE	Metastatectomia and standard treatment for resectable disease.	Rather than palliative chemotherapy, the intervention offered to participants is preoperative chemotherapy, resection of primary tumour and metastatectomia of oligometastatic spread to the liver. If fit for post-operative chemotherapy, this is offered as well.

Timeline

• Start date: 2020-12-01
• Primary completion: 2024-12-01
• Completion: 2024-12-01
• First posted: 2024-10-04
• Last updated: 2024-10-04

Locations

1 site across 1 country: Denmark